3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome
N. Spry, J. Harvey, C. Macleod, M. Borg, S.Y. Ngan, J.L. Millar, P. Graham, Y. Zissiadis, A. Kneebone, S. Carroll, T. Davies, W.H.H. Reece, Barry Iacopetta, D. Goldstein
Dive into the research topics of '3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome'. Together they form a unique fingerprint.